Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 61Carcinoma, Renal Cell 39Neoplasm Metastasis 38Neoplasms 24Kidney Neoplasms 20Neuroendocrine Tumors 19Recurrence 16Prostatic Neoplasms 15Head and Neck Neoplasms 13Tuberous Sclerosis 12Triple Negative Breast Neoplasms 12Lymphoma, Mantle-Cell 11Hodgkin Disease 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma 10Colorectal Neoplasms 10Waldenstrom Macroglobulinemia 9Stomach Neoplasms 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Glioma 9Glioblastoma 9Brain Neoplasms 9Sarcoma 8Pancreatic Neoplasms 8Melanoma 8Lymphoma, Follicular 8Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8

Interventions

Surveys and Questionnaires 7Standard of Care 5Sirolimus 5Bevacizumab 5temsirolimus 4Interviews as Topic 4Paclitaxel 3olaparib 2Vorinostat 2Olanzapine 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Everolimus 2Erlotinib Hydrochloride 2Dasatinib 2Cetuximab 2zaleplon 1vistusertib 1tilsotolimod 1pazopanib 1olanzapine-fluoxetine combination 1nimotuzumab 1liposomal doxorubicin 1capivasertib 1apatinib 1Videotape Recording 1Vemurafenib 1Valproic Acid 1Trastuzumab 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Advanced Cancer × Everolimus × Clear all
NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

NCT01596140 2020-06-04

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
27 enrolled
Other solid neoplasm

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡